Ikarian Capital, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.3B
Holdings
126
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (126 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —IMMUNOMEDICS INC | 16,100 | $571K | 0.05% | Call |
| 102 | —MYOVANT SCIENCES LTD | 25,999 | $536K | 0.04% | |
| 103 | —AXOVANT GENE THERAPIES | 188,884 | $533K | 0.04% | |
| 104 | —OBSEVA SA | 82,573 | $486K | 0.04% | |
| 105 | GILDGILEAD SCIENCES INC | 6,218 | $478K | 0.04% | |
| 106 | SRPTSAREPTA THERAPEUTICS INC | 2,600 | $417K | 0.03% | Call |
| 107 | —BAUDAX BIO INC | 100,000 | $415K | 0.03% | |
| 108 | GNFTYGENFIT S A | 64,027 | $353K | 0.03% | |
| 109 | ARNAEURARENA PHARMACEUTICALS INC | 5,000 | $315K | 0.03% | |
| 110 | —MILLENDO THERAPEUTICS INC | 135,193 | $238K | 0.02% | |
| 111 | SNDXSYNDAX PHARMACEUTICALS INC | 16,000 | $237K | 0.02% | |
| 112 | LEGNLEGEND BIOTECH CORP | 5,000 | $213K | 0.02% | |
| 113 | BIIBBIOGEN INC | 795 | $213K | 0.02% | |
| 114 | IWMISHARES TR | 1,154 | $165K | 0.01% | |
| 115 | —SIERRA ONCOLOGY INC | 9,658 | $118K | 0.01% | |
| 116 | ANABANAPTYSBIO INC | 4,581 | $102K | 0.01% | |
| 117 | —AETERNA ZENTARIS INC | 117,443 | $94K | 0.01% | |
| 118 | IM8NINSMED INC | 2,919 | $80K | 0.01% | |
| 119 | DTILPRECISION BIOSCIENCES INC | 8,812 | $73K | 0.01% | |
| 120 | APLSAPELLIS PHARMACEUTICALS INC | 2,126 | $69K | 0.01% | |
| 121 | —STEALTH BIOTHERAPEUTICS CORP | 37,597 | $69K | 0.01% | |
| 122 | —MAGENTA THERAPEUTICS INC | 8,674 | $65K | 0.01% | |
| 123 | ASNSUSDX4 PHARMACEUTICALS INC | 5,000 | $47K | 0.00% | |
| 124 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,739 | $46K | 0.00% | |
| 125 | —SUNESIS PHARMACEUTICALS INC | 111,445 | $29K | 0.00% | |
| 126 | VKTXVIKING THERAPEUTICS INC | 1,159 | $8K | 0.00% |
PreviousPage 2 of 2